CARMUSTINE for B-cell lymphoma refractory: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where CARMUSTINE was used for B-cell lymphoma refractory.
Most Reported Side Effects for CARMUSTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 454 | 13.5% | 109 | 154 |
| Febrile neutropenia | 297 | 8.8% | 44 | 97 |
| Myelodysplastic syndrome | 295 | 8.7% | 153 | 41 |
| Disease progression | 241 | 7.1% | 34 | 32 |
| Acute myeloid leukaemia | 180 | 5.3% | 134 | 43 |
| Thrombocytopenia | 174 | 5.2% | 34 | 32 |
| Pyrexia | 152 | 4.5% | 36 | 76 |
| Drug ineffective | 149 | 4.4% | 23 | 47 |
| Mucosal inflammation | 148 | 4.4% | 17 | 40 |
| Second primary malignancy | 141 | 4.2% | 82 | 52 |
| Infection | 139 | 4.1% | 77 | 37 |
| Diarrhoea | 138 | 4.1% | 27 | 52 |
| Product use in unapproved indication | 136 | 4.0% | 47 | 55 |
| Neutropenia | 127 | 3.8% | 42 | 40 |
| Haematotoxicity | 110 | 3.3% | 3 | 0 |
Other Indications for CARMUSTINE
Diffuse large b-cell lymphoma (551)
Bone marrow conditioning regimen (431)
Non-hodgkin's lymphoma (222)
Hodgkin's disease (206)
Product used for unknown indication (204)
Mantle cell lymphoma (183)
Plasma cell myeloma (137)
Central nervous system lymphoma (136)
B-cell lymphoma (128)
Lymphoma (128)
Other Drugs Used for B-cell lymphoma refractory
RITUXIMAB (103)
OBINUTUZUMAB (84)
CISPLATIN (53)
ETOPOSIDE (49)
DEXAMETHASONE (45)
AXICABTAGENE CILOLEUCEL (44)
CYCLOPHOSPHAMIDE (43)
CYTARABINE (40)
IBRUTINIB (39)
LENALIDOMIDE (36)